SPDR SP Profile

86.10
USD 0.44  0.51%
5%
71%

SPDR SP Summary

SPDR SP Biotech ETF [XBI] is traded in USA and was established 2006-01-31. The fund is classified under Health category within SPDR State Street Global Advisors family. SPDR SP Biotech ETF at this time have 5.36 B in net assets. , while the total return for the last 3 years was 15.85%.
Check SPDR SP Probability Of Bankruptcy

Geographic Allocation (%)

SPDR SP Biotech Currency Exposure (%)

 % of ETF 
      Currency 

Top Etf Constituents

SPDR SP Target Price Odds Analysis

Odds Below 86.1HorizonTargetOdds Above 86.1
51.46%30 days 86.10 48.46%
Based on normal probability distribution, the odds of SPDR SP to move above current price in 30 days from now is about 48.46% (This SPDR SP Biotech ETF probability density function shows the probability of SPDR SP Etf to fall within a particular range of prices over 30 days) .

SPDR SP Biotech Top Holders

SPDR SP Biotech Risk Profiles

SPDR SP Biotech Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of seventeen. SPDR SP Biotech Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe SPDR SP price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

SPDR SP Key Fundamentals

SPDR SP Against Markets

SPDR SP Current Ratings

SPDR SP Biotech ETF 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
1 
Equity ratings for SPDR SP Biotech ETF are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. SPDR SP is traded on Archipelago Exchange in USA. more
NameSPDR SP Biotech ETF
Vice PresidentMichael RileyView All
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerSSgA
ExchangeArchipelago Exchange
Etf FamilySPDR State Street Global Advisors
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone866 787 2257
CurrencyUSD - US Dollar
IssuerSSgA
DescriptionSPDR S&P Biotech ETF
Inception Date2006-01-31
BenchmarkS&P Biotechnology Select Industry TR USD
Entity TypeRegulated Investment Company
Asset Under Management4.88 Billion
Average Trading Valume4.23 Million
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorSSGA Funds Management, Inc.
AdvisorSSgA Funds Management, Inc.
CustodianState Street Bank and Trust Company
DistributorState Street Global Advisors Funds Distributors, LLC
Portfolio ManagerMichael Feehily, Karl Schneider, Raymond Donofrio
Transfer AgentState Street Bank and Trust Company
Fiscal Year EndJune 30
ExchangeNYSE Arca, Inc.
Number of Constituents127
Market MakerVirtu Financial
Total Expense0.35
Management Fee0.35
Nav Price95.93
Last Bear Mkt0.00%
Two Hundred Day Average93.93
Ytd13.19%
Average Daily Volume In Three Month3.91M
Fifty Two Week Low78.46
Last Bull Mkt0.00%
Average Daily Volume Last 10 Day6.46M
Fifty Two Week High101.55
One Month-4.19%
Fifty Day Average94.98
See also Your Current Watchlist. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Search macroaxis.com